Top Markets
Coin of the day
Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX
Rang in Aktien #42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$581.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Adynxx, Inc. (ADYX)

Kategorie

Kursverlauf für Adynxx, Inc. (ADYX)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $176.75 am 1998-12-01
Kursverlauf der Aktie von Adynxx, Inc. von 1998 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 5.44%
2024 -9.43%
2023 -16.00%
2022 -98.67%
2021 -95.38%
2020 -82.63%
2019 -91.35%
2018 7.40%
2017 -67.79%
2016 -71.93%
2015 -48.93%
2014 -38.71%
2013 222.40%
2012 -31.95%
2011 -49.51%
2010 -10.76%
2009 1.67%
2008 -66.17%
2007 -18.69%
2006 -63.01%
2005 -60.31%
2004 29.59%
2003 2,783.48%
2002 52.14%
2001 29.87%
2000 -64.49%
1999 125.40%
1998 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$741.32 8.41%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE